Literature DB >> 2414429

Plasma membrane calcium flux, protein kinase C activation and smooth muscle contraction.

J Forder, A Scriabine, H Rasmussen.   

Abstract

Isolated perfused rabbit ear arteries contract when treated with 12-O-tetradecanoylphorbol-13-acetate (TPA), an activator of the calcium-activated, phospholipid-dependent protein kinase or C-kinase. Under conditions where the calcium concentration in the perfusate is 1.5 mM and the potassium concentration is 4.8 mM, there is a latent period of 70 +/- 19 min (mean +/- S.E.M., n = 10) between TPA addition and the onset of the contractile response. Once initiated, the contractile response is progressive and sustained. When perfusion conditions are altered in such a way as to modify calcium flux across the plasma membrane (i.e., raising the extracellular calcium concentration to 2.5 mM Ca++, raising the extracellular potassium concentration to 10 mM, and/or preincubating the tissues in media containing 100 nM Bay K 8644, a potent calcium channel agonist), the latency period between TPA addition and initiation of the contractile response is significantly reduced (2.5 mM Ca++, 37 +/- 7 min; 10 mM K+ and 2.5 mM Ca++, 11 +/- 3 min; 100 nM Bay K 8644 and 1.5 mM Ca++, 20 +/- 7 min; 100 nM Bay K 8644 and 2.5 mM Ca2+, 8.5 +/- 1.7 min; 10 mM K+ and 100 nM Bay K 8644, 11 +/- 5 min). Likewise, the combination of 2.5 mM calcium, 100 nM Bay K 8644, and 3.3 microM ouabain results in a contractile response 4.5 +/- 2.0 min after TPA addition (means +/- S.E.M., n = 4). Control tissues (absence of TPA addition) run simultaneously show no contractile responses to the various Ca++ flux regulators even after 90 min of incubation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2414429

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  23 in total

Review 1.  Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension.

Authors:  H Reynaert; M G Thompson; T Thomas; A Geerts
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

Review 2.  Properties of calcium channels in cardiac muscle and vascular smooth muscle.

Authors:  N Sperelakis
Journal:  Mol Cell Biochem       Date:  1990-12-20       Impact factor: 3.396

3.  Contraction of vascular smooth muscle induced by phorbol 12,13 dibutyrate in human and rat pulmonary arteries.

Authors:  J P Savineau; R Marthan; H Crevel
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

4.  Endothelin-induced increases in vascular smooth muscle Ca2+ do not depend on dihydropyridine-sensitive Ca2+ channels.

Authors:  T Mitsuhashi; R C Morris; H E Ives
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

5.  Interaction of phorbol esters with Ca2+ channels in smooth muscle.

Authors:  M Spedding
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

6.  Endothelium-derived relaxing factor inhibits the formation of inositol trisphosphate by rabbit aorta.

Authors:  D Lang; M J Lewis
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

7.  PKC and Rho in vascular smooth muscle: activation by BOXes and SAH CSF.

Authors:  Gail J Pyne-Geithman; Sunil G Nair; Danielle N Caudell; Joseph F Clark
Journal:  Front Biosci       Date:  2008-01-01

8.  Stimulation of hepatic glycogenolysis by phorbol 12-myristate 13-acetate.

Authors:  T B Patel
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

9.  Phorbol 12,13-dibutyrate, an activator of protein kinase C, stimulates both contraction and Ca2+ fluxes in dog saphenous vein.

Authors:  P J Chiu; G Tetzloff; M Chatterjee; E J Sybertz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

10.  Phorbol ester cardiotoxicity: are .O2-radicals involved?

Authors:  E Esser; G Loschen; L Flohé
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.